Table 3.

Effect of clinical and molecular factors on PFS

FactorPFS [mean mos (95% CI)]P
EVI1 (low vs. high)99 (88–110) vs. 52 (35–68)0.001
Age (<18 vs. >18 years)63 (47–79) vs. 85 (67–104)0.149
WHO grade (II vs. III)89 (74–105) vs. 58 (41–75)0.040
Gender (male vs. female)68 (50–85) vs. 78 (60–96)0.313
Resection (incomplete vs. gross total)42 (26–59) vs. 97 (87–107)<0.001